Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 6/20 | 0.40 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.40 |
| ▸ | PAM | P19021 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | PLG | P00747 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.36 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1065353 | 1.00 | DGKA (0.42) | DGKATSHRLMNANFKB1PMP22 | |
| SCHEMBL515782 | 1.00 | DGKA (0.42) | DGKATSHRLMNANFKB1PMP22 | |
| SCHEMBL27738121 | 1.00 | DGKA (0.42) | DGKATSHRLMNANFKB1PMP22 | |
| SCHEMBL27672248 | 1.00 | DGKA (0.42) | DGKATSHRLMNANFKB1PMP22 | |
| SCHEMBL9593894 | 1.00 | DGKA (0.42) | DGKATSHRLMNANFKB1PMP22 | |
| SCHEMBL1064431 | 1.00 | DGKA (0.42) | DGKATSHRLMNANFKB1PMP22 | |
| SCHEMBL27705302 | 1.00 | DGKA (0.42) | DGKATSHRLMNANFKB1PMP22 | |
| SCHEMBL9593713 | 1.00 | DGKA (0.42) | DGKATSHRLMNANFKB1PMP22 | |
| SCHEMBL27569510 | 0.97 | DGKA (0.41) | DGKATSHRLMNANFKB1PMP22 | |
| SCHEMBL28175756 | 0.97 | DGKA (0.41) | DGKATSHRLMNANFKB1PMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 123 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113252806-A | Application of S-adenosyl homocysteine in preparation of product for diagnosing or treating kawasaki disease | 嘉兴学院 | 2021-08-13 | — | — | CN | claimed |
| US-9101662-B2 | Compositions with modulating agents | FOAMIX PHARMACEUTICALS LTD. (IL) | 2015-08-11 | — | — | US | claimed |
| US-8795693-B2 | Compositions with modulating agents | FOAMIX LTD. (IL) | 2014-08-05 | — | — | US | claimed |
| WO-2010017405-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF PAIN | HELLER ADAM (US) | 2010-02-11 | — | — | WO | claimed |
| CN-101619296-A | Streptomyces lactis and application thereof | GUANGDONG INST MICROBIOLOGY | 2010-01-06 | — | — | CN | claimed |
| EP-2120555-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF PAIN | Heller, Adam (US) | 2009-11-25 | — | — | EP | claimed |
| EP-2097065-A2 | FOAMABLE WATERLESS COMPOSITIONS WITH MODULATING AGENTS | Foamix Ltd. (IL) | 2009-09-09 | — | — | EP | claimed |
| CN-101525586-A | Streptomyces caeruleatus GIMN4.002 and application thereof | GUANGDONG INST MICROBIOLOGY | 2009-09-09 | — | — | CN | claimed |
| WO-2008152444-A2 | FOAMABLE WATERLESS COMPOSITIONS WITH MODULATING AGENTS | FOAMIX LTD. (US) | 2008-12-18 | — | — | WO | claimed |
| US-20080287866-A1 | Methods and compositions for the treatment of pain | HELLER ADAM | 2008-11-20 | — | — | US | claimed |
| US-20080206159-A1 | Drug mixture contains solvents, nonionic surfactants, gelling agent, therapeutic active agent, liquefied or compressed gas propellant; pressurized dispenser; treating skin diseases, dermal and mucosal delivery; stable and non-irritating emulsions | FOAMIX LTD. (IL) | 2008-08-28 | — | — | US | claimed |
| WO-2008094664-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF PAIN | HELLER ADAM (US) | 2008-08-07 | — | — | WO | claimed |
| EP-0848592-B1 | ANTISTRESS AGENTS FOR AQUATIC ANIMALS | BAENSCH TETRA WERKE (DE) | 2000-11-02 | — | — | EP | claimed |
| CN-118772242-A | CD137 specific bicyclic peptide ligands | 拜斯科技术开发有限公司 | 2024-10-15 | — | — | CN | disclosed |
| CN-111183147-B | CD137 specific bicyclic peptide ligands | 拜斯科技术开发有限公司 | 2024-07-05 | — | — | CN | disclosed |
| CN-117615794-A | Checkpoint inhibitors conjugated to IL-2 and uses thereof | 明峰治疗股份公司 | 2024-02-27 | — | — | CN | disclosed |
| US-4439199-A | TO ACTIVATE AN IMMUNE RESPONSE | ALZA CORPORATION (US) | 1984-03-27 | — | — | US | disclosed |
| US-4389486-A | SACCHAROPOLYSPORA HIRSUTA, WICH PRODUCES ANTIBIOTIC KA-6606 BY FERMENTATION | KOWA COMPANY, LTD. (JP) | 1983-06-21 | — | — | US | disclosed |
| US-4328211-A | Antibiotic Actinomadura-L-31 A, B | KAKEN CHEMICAL CO., LTD. (JP) | 1982-05-04 | — | — | US | disclosed |
| US-3991107-A | Haloamine transfer | NATIONAL PATENT DEVELOPMENT CORPORATION (US) | 1976-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080206159-A1 | Drug mixture contains solvents, nonionic surfactants, gelling agent, therapeutic active agent, liquefied or compressed gas propellant; pressurized dispenser; treating skin diseases, dermal and mucosal delivery; stable and non-irritating emulsions | CUTA, SLTM, SMO | DGKA 53/4885TSHR 4100/4885LMNA 1023/4885 |
| US-20080287866-A1 | Methods and compositions for the treatment of pain | ACHE, S100P, P2RX3 | DGKA 1354/4885TSHR 4339/4885LMNA 1174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.